Interactions médicamenteuses
Cyclosporine + Liposomal doxorubicin
Gravité: Majeure
Cyclosporine and Liposomal doxorubicin: major interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Cyclosporine inhibits P-glycoprotein and CYP3A4 and has been reported to increase doxorubicin exposure and toxicity, including myelosuppression. Cases of severe neutropenia and neurotoxicity have been reported with the combination of anthracyclines and cyclosporine. Additive immunosuppression further raises infection risk.
Ce que signifie cette interaction, en termes simples
Cyclosporine and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Pourquoi elle survient
Cyclosporine inhibits P-gp and CYP3A4, reducing doxorubicin clearance, with additive immunosuppression.
Conduite à tenir
Monitor blood counts, cardiac function and signs of infection closely, and consider reducing the doxorubicin dose. Avoid the combination when alternatives exist.
Questions à poser à votre pharmacien
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Cyclosporine et Liposomal doxorubicin, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.
Autres interactions de Liposomal doxorubicin
- Dengue vaccine + Liposomal doxorubicin Contre-indiquée
- Belatacept + Liposomal doxorubicin Majeure
- Dronedarone + Liposomal doxorubicin Majeure
- Elvitegravir / cobicistat / emtricitabine / tenofovir df + Liposomal doxorubicin Majeure
- Fingolimod + Liposomal doxorubicin Majeure
- Ganciclovir + Liposomal doxorubicin Majeure
Questions fréquentes
Can I take Cyclosporine with Liposomal doxorubicin?
MediHelp rates the interaction as major. Cyclosporine and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Cyclosporine inhibits P-glycoprotein and CYP3A4 and has been reported to increase doxorubicin exposure and toxicity, including myelosuppression. Cases of severe neutropenia and neurotoxicity have been reported with the combination of anthracyclines and cyclosporine. Additive immunosuppression further raises infection risk.
How serious is the interaction between Cyclosporine and Liposomal doxorubicin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts, cardiac function and signs of infection closely, and consider reducing the doxorubicin dose. Avoid the combination when alternatives exist.
What other medicines interact with Liposomal doxorubicin?
MediHelp also lists interactions of Liposomal doxorubicin with, for example, Dengue vaccine, Belatacept, Dronedarone. The full list is on the Liposomal doxorubicin page.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
